Intellipharmaceutics International Inc. (IPCIF)

USD 0.15

(50.0%)

Inventory Summary of Intellipharmaceutics International Inc.

  • Intellipharmaceutics International Inc.'s latest annual inventory in 2023 was 1.00 USD , down 0.0% from previous year.
  • Intellipharmaceutics International Inc.'s latest quarterly inventory in 2024 Q3 was - USD , down 0.0% from previous quarter.
  • Intellipharmaceutics International Inc. reported annual inventory of - USD in 2022, down -100.0% from previous year.
  • Intellipharmaceutics International Inc. reported annual inventory of 112.67 Thousand USD in 2021, down 0.0% from previous year.
  • Intellipharmaceutics International Inc. reported quarterly inventory of - USD for 2024 Q3, down 0.0% from previous quarter.
  • Intellipharmaceutics International Inc. reported quarterly inventory of - USD for 2024 Q1, down -100.0% from previous quarter.

Annual Inventory Chart of Intellipharmaceutics International Inc. (2023 - 1997)

Historical Annual Inventory of Intellipharmaceutics International Inc. (2023 - 1997)

Year Inventory Inventory Growth
2023 1.00 USD 0.0%
2022 - USD -100.0%
2021 112.67 Thousand USD 0.0%
2020 112.67 Thousand USD -55.23%
2019 251.65 Thousand USD 117.57%
2018 115.66 Thousand USD 116.98%
2017 -681.13 Thousand USD -267.31%
2016 -185.43 Thousand USD -281.57%
2015 102.13 Thousand USD -41.67%
2014 175.08 Thousand USD 1304.38%
2013 12.46 Thousand USD 0.0%
2012 - USD 100.0%
2011 -32.86 Thousand USD 92.61%
2010 -444.76 Thousand USD 0.0%
2009 - USD -100.0%
2008 1.36 Million USD 28.45%
2007 1.06 Million USD -33.49%
2006 1.59 Million USD -32.47%
2005 2.36 Million USD 0.0%
2004 - USD -100.0%
2003 1.68 Million USD 0.0%
2002 - USD 0.0%
2001 - USD -100.0%
2000 100.05 Thousand USD -49.89%
1999 199.67 Thousand USD 0.0%
1998 - USD 0.0%
1997 - USD 0.0%

Peer Inventory Comparison of Intellipharmaceutics International Inc.

Name Inventory Inventory Difference
Eiger BioPharmaceuticals, Inc. 1.55 Million USD 100.0%
Nanobac Pharmaceuticals, Incorporated 10.3 Thousand USD 99.99%
SQZ Biotechnologies Company - USD -Infinity%
Evofem Biosciences, Inc. 1.69 Million USD 100.0%
Santhera Pharmaceuticals Holding AG 2.15 Million USD 100.0%
Mesoblast Limited 1.00 USD 0.0%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 89.4 Million USD 100.0%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. -94.61 Thousand USD 100.001%
Marizyme, Inc. 24.85 Thousand USD 99.996%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation 16 Thousand USD 99.994%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. - USD -Infinity%
MultiCell Technologies, Inc. - USD -Infinity%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 784 Thousand USD 100.0%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 1.71 Million USD 100.0%
Neon Bloom, Inc. 7938.00 USD 99.987%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 56.76 Million USD 100.0%
Oncotelic Therapeutics, Inc. - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 22.57 Thousand USD 99.996%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 1.36 Million USD 100.0%
IMV Inc. 2.00 USD 50.0%
Acro Biomedical Co., Ltd. 12 Thousand USD 99.992%
Curative Biotechnology, Inc. -115.62 Thousand USD 100.001%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. 90.41 Thousand USD 99.999%
HST Global, Inc. - USD -Infinity%
CSL Limited 5.96 Billion USD 100.0%
Halberd Corporation - USD -Infinity%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. 2.37 Million USD 100.0%
Affymax, Inc. - USD -Infinity%
SYBLEU INC - USD -Infinity%
Nuo Therapeutics, Inc. 209.58 Thousand USD 100.0%
argenx SE 310.55 Million USD 100.0%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. - USD -Infinity%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 11.52 Thousand USD 99.991%
Zenith Capital Corp. 3.00 USD 66.667%
Genscript Biotech Corporation 53.33 Million USD 100.0%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 50 Thousand USD 99.998%
WPD Pharmaceuticals Inc. 0.25 USD -300.0%
American Oriental Bioengineering, Inc. 20.57 Million USD 100.0%
Provectus Biopharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 12.83 Million USD 100.0%
Cotinga Pharmaceuticals Inc. 0.98 USD -2.041%
BioStem Technologies, Inc. 658.67 Thousand USD 100.0%
ONE Bio Corp. 4.5 Million USD 100.0%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. 1.00 USD 0.0%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. - USD -Infinity%
Regen BioPharma, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. -20.67 Thousand USD 100.005%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. -8.71 USD 111.481%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. - USD -Infinity%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 1.26 Million USD 100.0%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 15 Million USD 100.0%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. - USD -Infinity%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc - USD -Infinity%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 1.00 USD 0.0%
IntelGenx Technologies Corp. 71 Thousand USD 99.999%
Gelesis Holdings, Inc. 6.86 Million USD 100.0%
CSL Limited 5.96 Billion USD 100.0%
Cellectis S.A. 1.00 USD 0.0%